A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies

PHASE3CompletedINTERVENTIONAL
Enrollment

355

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Sarcoma
Interventions
DRUG

OMBRABULIN (AVE8062)

I.V. infusion followed by administration of cisplatin

DRUG

Placebo

I.V. infusion followed by administration of cisplatin

Trial Locations (45)

1134

Investigational Site Number 348001, Budapest

1200

Investigational Site Number 056001, Brussels

4000

Investigational Site Number 056005, Liège

4032

Investigational Site Number 348002, Debrecen

7100

Investigational Site Number 056004, Haine-Saint-Paul

11000

Investigational Site Number 891001, Belgrade

13385

Investigational Site Number 250010, Marseille

20089

Investigational Site Number 380002, Rozzano

20133

Investigational Site Number 380003, Milan

20141

Investigational Site Number 380004, Milan

21079

Investigational Site Number 250002, Dijon

21204

Investigational Site Number 891002, Kamenitz

28040

Investigational Site Number 724001, Madrid

31008

Investigational Site Number 724003, Pamplona

32806

Investigational Site Number 840003, Orlando

33076

Investigational Site Number 250008, Bordeaux

33081

Investigational Site Number 380001, Aviano

34094

Investigational Site Number 250006, Montpellier

35000

Investigational Site Number 250005, Rennes

42270

Investigational Site Number 250012, Saint-Priest-en-Jarez

44800

Investigational Site Number 250009, Saint-Herblain

59010

Investigational Site Number 250004, Lille

60153

Investigational Site Number 840005, Maywood

69437

Investigational Site Number 250001, Lyon

78229

Investigational Site Number 840001, San Antonio

90403

Investigational Site Number 840004, Santa Monica

92210

Investigational Site Number 250003, Saint-Cloud

110076

Investigational Site Number 356004, New Delhi

500033

Investigational Site Number 356003, Hyderabad

560054

Investigational Site Number 356005, Bangalore

07103

Investigational Site Number 840002, Newark

Unknown

Investigational Site Number 840007, Philadelphia

30130-100

Investigational Site Number 076007, Belo Horizonte

74070-040

Investigational Site Number 076008, Goiânia

98700 000

Investigational Site Number 076003, Ijuí

17210-120

Investigational Site Number 076004, Jaú

93511 970

Investigational Site Number 076006, Novo Hamburgo

90020-090

Investigational Site Number 076002, Porto Alegre

90035 003

Investigational Site Number 076005, Porto Alegre

20230-130

Investigational Site Number 076009, Rio de Janeiro

06189

Investigational Site Number 250007, Nice

08025

Investigational Site Number 724004, Barcelona

CH63 4JY

Investigational Site Number 826001, Bebington

BS2 8ED

Investigational Site Number 826003, Bristol

NE4 6BE

Investigational Site Number 826002, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00699517 - A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies | Biotech Hunter | Biotech Hunter